- Cikk címe: Risk-sharing, individual price agreements and reference pricing –recent developments in Polish pharmaceutical policy
- Szerzők: MD Phd Bochenek Tomasz
- Intézmények: Department of Drug Management
- Évfolyam: XI. évfolyam
- Lapszám: 2012. / 10
- Hónap: december
- Oldal: 71-73
- Terjedelem: 3
- Rovat: EGÉSZSÉG-GAZDASÁGTAN
- Alrovat: FINANSZÍROZÁS
Angol absztrakt:
After a long period of stagnancy in pricing and reimbursement policy, the profound changes have occurred in the second half of 2011 and beginning of 2012 in Poland, after introduction of the Reimbursement Law. One of the most important novelties was introduction of risk-sharing and individual price agreements between pharmaceutical industry and the Minister of Health. Reference pricing has been used in Poland for 20 years and recent reforms have strengthened its role. Mutual exchange of specialist knowledge and experiences from the field of pharmaceutical pricing and reimbursement among countries, which have similar economies and similar health care systems, is strongly required in the era of financial austerities.
XI. évfolyam
2012. / 10. lapszám december
| Szerző | Intézmény |
|---|---|
| Szerző: MD Phd Bochenek Tomasz | Intézmény: Department of Drug Management |
[1] OECD: OECD.StatExtracts (http://stats.oecd.org/Index.aspx?DataSetCode=SHA), 2012, date of visit: 07.08.2012
[2] Ustawa z dnia 12 maja 2011 r. o refundacji leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych (The Reimburse - ment Law), Dz. U. z dnia 13 czerwca 2011 r. (in Polish)
[3] EEC, Transparency Directive 89/105/EEC, Trans - parency of measures relating to pricing and reimbursement of medicinal products
[4] Ministerstwo zdrowia (the Ministry of Health), „założenia zmian w systemie refundacji leków” („Guidelines for changes in the system of pharmaceutical reimbursement”), Ministerstwo zdrowia, Warszawa, 15 września 2005r, 2-25 (in Polish)
[5] Adamski J et al. „Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers” BMC Health Services Research, 2012, 10: 153
[6] Bochenek T, Kozierkiewicz A, “Ceny i refundacja leków” („Pricing and reimbursement of pharmaceuticals”), Termedia Wydawnictwa Medyczne, Poznań, 2009, 13-95 (in Polish)
[7] Ioannides–Demos L, Ibrahim J, McNeil J, “Referencebased pricing schemes”, Pharmacoeconomics, 2002, 20 (9), 577-591
[8] Kalo z, “Pricing and reimbursement of pharmaceuticals in Central-Eastern European coutries”, VI-th National Training and Conference on Health Economics: Health Economics, growing importance in scarcity, META – Hungarian Health Economics Association, 20.06.2012-21.06.2012, Budapest, Hungary (conference materials)